Omnicell (OMCL) Long-Term Debt Repayments (2019 - 2020)
Omnicell (OMCL) reported Long-Term Debt Repayments of $150.0 million for Q3 2020, up 200.0% on a QoQ basis from $50.0 million in Q1 2020.
Omnicell (OMCL) has 2 years of Long-Term Debt Repayments data on file, last reported at $150.0 million in Q3 2020.
- Quarterly Long-Term Debt Repayments changed N/A year-over-year to $150.0 million in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $150.0 million (up 87.5% YoY) and the FY2025 annual result came in at $175.0 million, changed N/A from the prior year.
- Long-Term Debt Repayments climbed to $150.0 million in Q3 2020 per OMCL's latest filing, from $50.0 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $150.0 million in Q3 2020 and bottomed at $21.0 million in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 12.35 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 15.00 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 23.55 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 150.00 Mn |
| Sep 30, 2020 | 150.00 Mn |
| Mar 31, 2020 | 50.00 Mn |
| Mar 31, 2020 | 50.00 Mn |
| Dec 31, 2019 | 30.00 Mn |
| Dec 31, 2019 | 30.00 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Mar 31, 2019 | 39.00 Mn |
| Mar 31, 2019 | 39.00 Mn |